Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Jing Quan Lim1,2,3, Dachuan Huang2,3, Tiffany Tang4

  • 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.

Leukemia
|August 6, 2020
PubMed
Abstract

No abstract available in PubMed .